CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop stable peptides for treating inflammatory bowel diseases by targeting biofilms and promoting gut healing. It focuses on creating nanoparticles for effective drug delivery, enhancing treatment for gastrointestinal disorders through innovative peptide design and synthesis.
Inflammatory bowel diseases (IBD) affect more than 2 million residents in Europe.
Currently, there is no cure for IBD, and treatment focuses on alleviating symptoms.
Injured/compromised mucosal barrier and GI biofilms are common pathophysiological deviations in IBD.
The overall aim of this project is to develop gut-stable peptides effective against biofilms, peptides suitable for wound-healing treatment, and nanocarrier systems for targeted delivery.
In particular, I will focus on developing new…
UNIVERSITAT WIEN
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
